PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3

[1]  F. Lang,et al.  Modulation of the Voltage-Gated Potassium Channel Kv1.5 by the SGK1 Protein Kinase Involves Inhibition of Channel Ubiquitination , 2008, Cellular Physiology and Biochemistry.

[2]  H. Daniel,et al.  The Peptide Transporter PEPT2 is Targeted by the Protein Kinase SGK1 and the Scaffold Protein NHERF2 , 2008, Cellular Physiology and Biochemistry.

[3]  F. Lang,et al.  A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels , 2008, Psychopharmacology.

[4]  J. Loeb,et al.  Focal reduction of neuronal glutamate transporters in human neocortical epilepsy , 2008, Epilepsia.

[5]  Jürgen Gallinat,et al.  Molecular Mechanisms of Schizophrenia , 2007, Cellular Physiology and Biochemistry.

[6]  F. Lang,et al.  PIKfyve in the SGK1 Mediated Regulation of the Creatine Transporter SLC6A8 , 2007, Cellular Physiology and Biochemistry.

[7]  Lin He,et al.  The PIP5K2A gene and schizophrenia in the Chinese population — A case-control study , 2007, Schizophrenia Research.

[8]  D. Brown,et al.  Regulation of M(Kv7.2/7.3) channels in neurons by PIP2 and products of PIP2 hydrolysis: significance for receptor‐mediated inhibition , 2007, The Journal of physiology.

[9]  A. Deimling,et al.  Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS , 2007, Regulatory Peptides.

[10]  Y. Fukumaki,et al.  Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  R. Sinke,et al.  The PIP5K2A and RGS4 genes are differentially associated with deficit and non‐deficit schizophrenia , 2007, Genes, brain, and behavior.

[12]  M. Harte,et al.  Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. , 2007, Journal of neural transmission. Supplementum.

[13]  A. Nieoullon,et al.  The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? , 2006, Journal of neurochemistry.

[14]  W. Maier,et al.  Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia , 2006, Molecular Psychiatry.

[15]  V. Haroutunian,et al.  Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia , 2006, Synapse.

[16]  Z. Zuo,et al.  Effects of chronic exposure to ethanol on glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement. , 2005, Alcoholism, clinical and experimental research.

[17]  P. Delmas,et al.  Pathways modulating neural KCNQ/M (Kv7) potassium channels , 2005, Nature Reviews Neuroscience.

[18]  H. Lachman,et al.  Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia , 2005, Psychiatric genetics.

[19]  J. Rothstein,et al.  Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly. , 2005, Brain research. Developmental brain research.

[20]  S. Bröer,et al.  Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 [correction]. , 2004, Investigative ophthalmology & visual science.

[21]  S. Bröer,et al.  Retinal colocalization and in vitro interaction of the glutamate receptor EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 , 2004 .

[22]  J. Rothstein,et al.  Glutamate transporter expression and function in human glial progenitors , 2004, Glia.

[23]  J. Rothstein,et al.  Climbing Fiber Activation of EAAT4 Transporters and Kainate Receptors in Cerebellar Purkinje Cells , 2004, The Journal of Neuroscience.

[24]  H. Lachman,et al.  Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p‐Linked Psychiatric Disorders , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  F. Fujiyama,et al.  Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight , 2003, The European journal of neuroscience.

[26]  D. Braus,et al.  Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain , 2003, Neuroscience Letters.

[27]  R. Anderson,et al.  Phosphatidylinositol Phosphate Kinases Put PI4,5P2 in Its Place , 2003, The Journal of Membrane Biology.

[28]  C. Zwingmann,et al.  Effects of ammonia on high affinity glutamate uptake and glutamate transporter EAAT3 expression in cultured rat cerebellar granule cells , 2003, Neurochemistry International.

[29]  S. Amara,et al.  Excitatory amino acid transporters: keeping up with glutamate , 2002, Neurochemistry International.

[30]  P. Crino,et al.  Increased Expression of the Neuronal Glutamate Transporter (EAAT3/EAAC1) in Hippocampal and Neocortical Epilepsy , 2002, Epilepsia.

[31]  J. Meador-Woodruff,et al.  Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder , 2002, Neuropsychopharmacology.

[32]  P. V. van Rijen,et al.  Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. , 2002, Brain : a journal of neurology.

[33]  F. Pallardó,et al.  Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress , 2001, Brain Research.

[34]  R. E. Smith,et al.  Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. , 2001, The American journal of psychiatry.

[35]  Florian Lang,et al.  The Use of Xenopus laevis Oocytes for the Functional Characterization of Heterologously Expressed Membrane Proteins , 2000, Cellular Physiology and Biochemistry.

[36]  C. Nichols,et al.  Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Viña,et al.  Na+-dependent Glutamate Transporters (EAAT1, EAAT2, and EAAT3) of the Blood-Brain Barrier , 1999, The Journal of Biological Chemistry.

[38]  J. Kunz,et al.  Phosphatidylinositol Phosphate Kinases, a Multifaceted Family of Signaling Enzymes* , 1999, The Journal of Biological Chemistry.

[39]  M. Baudry,et al.  Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. , 1999, Brain research. Molecular brain research.

[40]  G. Ojemann,et al.  Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy , 1999, Neurology.

[41]  J. Rothstein,et al.  Multiple Signaling Pathways Regulate Cell Surface Expression and Activity of the Excitatory Amino Acid Carrier 1 Subtype of Glu Transporter in C6 Glioma , 1998, The Journal of Neuroscience.

[42]  L. Cantley,et al.  A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate , 1997, Nature.

[43]  J. Morrison,et al.  Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody , 1997, Brain Research.

[44]  J. Rothstein,et al.  Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4 , 1997, Neuroscience.

[45]  R. Blakely,et al.  Protein Kinase C Activation Regulates Human Serotonin Transporters in HEK-293 Cells via Altered Cell Surface Expression , 1997, The Journal of Neuroscience.

[46]  M. Robinson,et al.  Rapid Stimulation of EAAC1‐Mediated Na+‐Dependent l‐Glutamate Transport Activity in C6 Glioma Cells by Phorbol Ester , 1996, Journal of neurochemistry.

[47]  J. Rothstein,et al.  Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1). , 1996, Molecular pharmacology.